A Phase 1 Study of 1-Methyl-D-tryptophan (NSC-721782) in Combination With Docetaxel in Metastatic Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2014
At a glance
- Drugs Indoximod (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions
- 11 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Sep 2013 Planned End Date changed from 1 Oct 2013 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 23 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.